ask="24.50"
ask_size="100"
average_daily_volume="103067"
bid="N/A"
bid_size="N/A"
book_value="2.46"
change="+0.00"
change_from_200_day_moving_average="-2.35"
change_from_50_day_moving_average="0.77"
change_from_52_week_high="-11.00"
change_From_52_week_low="2.20"
change_in_percent="+0.00%"
close="6.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.01"
ebitda="-21.58M"
eps_estimate_current_year="-3.31"
eps_estimate_next_quarter="-0.89"
eps_estimate_next_year="-2.39"
ex_dividend_date="N/A"
float_shares="6470000"
high="6.90"
high_52_weeks="17.70"
last_trade_date="3/17/2017"
last_trade_price="6.70"
last_trade_size="600"
last_trade_time="4:00pm"
low="6.60"
low_52_weeks="4.50"
market_capitalization="52.56M"
moving_average_200_day="9.05"
moving_average_50_day="5.93"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.75"
open="6.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.99%"
percent_change_from_50_day_moving_average="+12.98%"
percent_change_from_52_week_high="-62.15%"
percent_change_from_52_week_low="+48.89%"
previous_close="6.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.72"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7845000"
short_ratio="2.43"
stock_exchange="NCM"
symbol="TRIL"
volume="103007"
weeks_range_52="4.50 - 17.70"
